Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2036588461', 'doi': 'https://doi.org/10.1097/01.ju.0000138157.46464.6e', 'title': 'CHEMOSENSITIZATION OF BLADDER CANCER CELL LINES BY HUMAN TELOMERASE REVERSE TRANSCRIPTASE ANTISENSE TREATMENT', 'display_name': 'CHEMOSENSITIZATION OF BLADDER CANCER CELL LINES BY HUMAN TELOMERASE REVERSE TRANSCRIPTASE ANTISENSE TREATMENT', 'publication_year': 2004, 'publication_date': '2004-10-08', 'ids': {'openalex': 'https://openalex.org/W2036588461', 'doi': 'https://doi.org/10.1097/01.ju.0000138157.46464.6e', 'mag': '2036588461', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15540782'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/01.ju.0000138157.46464.6e', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5014363552', 'display_name': 'Kai Kraemer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I78650965', 'display_name': 'TU Dresden', 'ror': 'https://ror.org/042aqky30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I78650965']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'KAI KRAEMER', 'raw_affiliation_strings': ['From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany', 'institution_ids': ['https://openalex.org/I78650965']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039751847', 'display_name': 'Susanne Fuessel', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I78650965', 'display_name': 'TU Dresden', 'ror': 'https://ror.org/042aqky30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I78650965']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'SUSANNE FUESSEL', 'raw_affiliation_strings': ['From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany', 'institution_ids': ['https://openalex.org/I78650965']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004714551', 'display_name': 'Matthias Kotzsch', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I78650965', 'display_name': 'TU Dresden', 'ror': 'https://ror.org/042aqky30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I78650965']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'MATTHIAS KOTZSCH', 'raw_affiliation_strings': ['From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany', 'institution_ids': ['https://openalex.org/I78650965']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035131751', 'display_name': 'Shuangli Ning', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I78650965', 'display_name': 'TU Dresden', 'ror': 'https://ror.org/042aqky30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I78650965']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'SHUANGLI NING', 'raw_affiliation_strings': ['From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany', 'institution_ids': ['https://openalex.org/I78650965']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101712096', 'display_name': 'U. Schmidt', 'orcid': 'https://orcid.org/0000-0003-1777-3010'}, 'institutions': [{'id': 'https://openalex.org/I78650965', 'display_name': 'TU Dresden', 'ror': 'https://ror.org/042aqky30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I78650965']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'UTA SCHMIDT', 'raw_affiliation_strings': ['From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany', 'institution_ids': ['https://openalex.org/I78650965']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065289402', 'display_name': 'Manfred P. Wirth', 'orcid': 'https://orcid.org/0000-0002-3094-4227'}, 'institutions': [{'id': 'https://openalex.org/I78650965', 'display_name': 'TU Dresden', 'ror': 'https://ror.org/042aqky30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I78650965']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'MANFRED P. WIRTH', 'raw_affiliation_strings': ['From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany', 'institution_ids': ['https://openalex.org/I78650965']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5039027824', 'display_name': 'Axel Meye', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I78650965', 'display_name': 'TU Dresden', 'ror': 'https://ror.org/042aqky30', 'country_code': 'DE', 'type': 'education', 'lineage': ['https://openalex.org/I78650965']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'AXEL MEYE', 'raw_affiliation_strings': ['From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany'], 'affiliations': [{'raw_affiliation_string': 'From the Department of Urology and Institute of Pathology (MK), Technical University Dresden, Dresden, Germany', 'institution_ids': ['https://openalex.org/I78650965']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 6.708, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 35, 'citation_normalized_percentile': {'value': 0.810445, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '172', 'issue': '5', 'first_page': '2023', 'last_page': '2028'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10458', 'display_name': 'Diagnosis and Treatment of Bladder Cancer', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10458', 'display_name': 'Diagnosis and Treatment of Bladder Cancer', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12996', 'display_name': 'Engineering Bacteria for Cancer Treatment', 'score': 0.99, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12264', 'display_name': 'Tissue Engineering and Regenerative Medicine', 'score': 0.9891, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bladder-cancer', 'display_name': 'Bladder Cancer', 'score': 0.554346}, {'id': 'https://openalex.org/keywords/tumor-targeting', 'display_name': 'Tumor Targeting', 'score': 0.548385}, {'id': 'https://openalex.org/keywords/tumor-regression', 'display_name': 'Tumor Regression', 'score': 0.540696}, {'id': 'https://openalex.org/keywords/metastatic-bladder-cancer', 'display_name': 'Metastatic Bladder Cancer', 'score': 0.531833}, {'id': 'https://openalex.org/keywords/cancer-metabolism', 'display_name': 'Cancer Metabolism', 'score': 0.530018}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.88154733}, {'id': 'https://openalex.org/C125593758', 'wikidata': 'https://www.wikidata.org/wiki/Q15315135', 'display_name': 'Telomerase reverse transcriptase', 'level': 4, 'score': 0.86146116}, {'id': 'https://openalex.org/C156719811', 'wikidata': 'https://www.wikidata.org/wiki/Q28774', 'display_name': 'Reverse transcriptase', 'level': 4, 'score': 0.7273939}, {'id': 'https://openalex.org/C94581717', 'wikidata': 'https://www.wikidata.org/wiki/Q331839', 'display_name': 'Telomerase', 'level': 3, 'score': 0.67683876}, {'id': 'https://openalex.org/C2780352672', 'wikidata': 'https://www.wikidata.org/wiki/Q504775', 'display_name': 'Bladder cancer', 'level': 3, 'score': 0.5827002}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5351639}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.454079}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.34651542}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.19182515}, {'id': 'https://openalex.org/C67705224', 'wikidata': 'https://www.wikidata.org/wiki/Q11053', 'display_name': 'RNA', 'level': 3, 'score': 0.19022816}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.09891155}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.08721799}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.066025704}], 'mesh': [{'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D016376', 'descriptor_name': 'Oligonucleotides, Antisense', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D019098', 'descriptor_name': 'Telomerase', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D002455', 'descriptor_name': 'Cell Division', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002455', 'descriptor_name': 'Cell Division', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004268', 'descriptor_name': 'DNA-Binding Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004359', 'descriptor_name': 'Drug Therapy, Combination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016376', 'descriptor_name': 'Oligonucleotides, Antisense', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019098', 'descriptor_name': 'Telomerase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/01.ju.0000138157.46464.6e', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15540782', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.86}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W1545398558', 'https://openalex.org/W1862964936', 'https://openalex.org/W2022328735', 'https://openalex.org/W2025971678', 'https://openalex.org/W2029670360', 'https://openalex.org/W2029854126', 'https://openalex.org/W2044493529', 'https://openalex.org/W2058553011', 'https://openalex.org/W2073535390', 'https://openalex.org/W2076309858', 'https://openalex.org/W2095287544', 'https://openalex.org/W2100631929', 'https://openalex.org/W2113089637', 'https://openalex.org/W2116648662', 'https://openalex.org/W2131450855', 'https://openalex.org/W2145344158', 'https://openalex.org/W2147730379', 'https://openalex.org/W2160462470', 'https://openalex.org/W2164277862', 'https://openalex.org/W2328187760', 'https://openalex.org/W2396402727'], 'related_works': ['https://openalex.org/W841528190', 'https://openalex.org/W3031429470', 'https://openalex.org/W3029558248', 'https://openalex.org/W3027313353', 'https://openalex.org/W2362115979', 'https://openalex.org/W2285184359', 'https://openalex.org/W2178340069', 'https://openalex.org/W2175618367', 'https://openalex.org/W2079293009', 'https://openalex.org/W1965709176'], 'abstract_inverted_index': {'No': [0], 'AccessJournal': [1], 'of': [2, 131, 135, 172, 175, 189, 212, 216, 252, 289, 300, 336, 356, 363, 381, 395, 400, 416, 444, 450, 467, 481, 502, 517, 556, 574, 592, 597, 613, 622, 634, 641, 676, 682, 699, 708, 729, 774, 803, 809, 830, 834, 888, 938], 'UrologyInvestigative': [3], 'Urology1': [4], 'Nov': [5], '2004CHEMOSENSITIZATION': [6], 'OF': [7, 924, 932], 'BLADDER': [8, 925], 'CANCER': [9, 926], 'CELL': [10], 'LINES': [11], 'BY': [12], 'HUMAN': [13], 'TELOMERASE': [14], 'REVERSE': [15], 'TRANSCRIPTASE': [16], 'ANTISENSE': [17, 922], 'TREATMENT': [18], 'KAI': [19, 35, 968], 'KRAEMER,': [20], 'SUSANNE': [21, 44, 975], 'FUESSEL,': [22], 'MATTHIAS': [23, 53, 982], 'KOTZSCH,': [24], 'SHUANGLI': [25, 62, 989], 'NING,': [26], 'UTA': [27, 71, 996], 'SCHMIDT,': [28], 'MANFRED': [29, 80, 1003], 'P.': [30, 81, 83, 1004], 'WIRTH,': [31], 'and': [32, 98, 107, 150, 165, 170, 206, 219, 231, 250, 377, 423, 429, 447, 537, 541, 616, 731, 750, 755, 782, 832, 872, 882, 914, 1019], 'AXEL': [33, 108, 1027], 'MEYE': [34, 110, 912, 1028], 'KRAEMERKAI': [36], 'KRAEMER': [37, 902, 969], 'More': [38, 47, 56, 65, 74, 101, 111, 970, 977, 984, 991, 998, 1022, 1029], 'articles': [39, 48, 57, 66, 75, 102, 112, 971, 978, 985, 992, 999, 1023, 1030], 'by': [40, 49, 58, 67, 76, 103, 113, 223, 246, 366, 421, 753, 843, 959, 972, 979, 986, 993, 1000, 1024, 1031], 'this': [41, 50, 59, 68, 77, 104, 114, 973, 980, 987, 994, 1001, 1025, 1032], 'author': [42, 51, 60, 69, 78, 105, 115, 974, 981, 988, 995, 1002, 1026, 1033], ',': [43, 52, 61, 70, 79, 106], 'FUESSELSUSANNE': [45], 'FUESSEL': [46, 904, 976], 'KOTZSCHMATTHIAS': [54], 'KOTZSCH': [55, 906, 983], 'NINGSHUANGLI': [63], 'NING': [64, 990], 'SCHMIDTUTA': [72], 'SCHMIDT': [73, 908, 997], 'WIRTHMANFRED': [82], 'WIRTH': [84, 910, 1005], 'Financial': [85, 1006], 'interest': [86, 1007], 'and/or': [87, 1008], 'other': [88, 1009], 'relationship': [89, 1010], 'with': [90, 194, 225, 279, 342, 350, 521, 534, 702, 813, 817, 1011], 'AstraZeneca,': [91, 1012], 'Takeda,': [92, 1013], 'Pfizer,': [93, 1014], 'GlaxoSmithKline,': [94, 1015], 'Novartis,': [95, 1016], 'MSD,': [96, 1017], 'Apogepha': [97, 1018], 'GPC': [99, 1020], 'Biotech': [100, 1021], 'MEYEAXEL': [109], 'View': [116], 'All': [117, 269, 327, 1035], 'Author': [118], 'Informationhttps://doi.org/10.1097/01.ju.0000138157.46464.6eAboutFull': [119], 'TextPDF': [120], 'ToolsAdd': [121], 'to': [122, 139, 167, 241, 273, 315, 319, 339, 483, 570, 602, 645], 'favoritesDownload': [123], 'CitationsTrack': [124], 'CitationsPermissionsReprints': [125], 'ShareFacebookLinked': [126], 'InTwitterEmail': [127], 'Abstract': [128], 'Purpose:': [129], 'Responses': [130], 'transitional': [132, 397, 787], 'cell': [133, 238, 270, 398, 553, 665, 761, 788], 'carcinoma': [134, 399], 'the': [136, 168, 173, 213, 226, 274, 292, 298, 334, 361, 379, 401, 465, 500, 571, 575, 595, 620, 680, 706, 828], 'bladder': [137, 417, 504, 736, 786], '(TCC)': [138], 'commonly': [140], 'used': [141], 'chemotherapy': [142, 196, 376], 'agents': [143, 276, 684], 'such': [144], 'as': [145, 180, 262, 383, 725], 'mitomycin': [146], 'C': [147], '(MMC),': [148], 'cisplatin': [149, 218], 'gemcitabine': [151, 220, 732, 756, 814], 'are': [152], 'often': [153], 'disappointing.': [154], 'Since': [155], 'human': [156, 503, 518, 535, 580, 598, 642, 663, 677, 735, 758, 785], 'telomerase': [157, 557, 593, 614, 635, 660, 678, 700], 'reverse': [158], 'transcriptase': [159], '(hTERT)': [160], 'is': [161, 178, 877], 'tumor': [162, 581], 'specifically': [163, 332, 498], 'expressed': [164], 'contributes': [166, 569], 'immortality': [169], 'malignancy': [171], 'majority': [174, 299], 'tumors,': [176], 'it': [177], 'regarded': [179], 'a': [181, 263, 285, 372, 384, 387, 460, 726], 'suitable': [182], 'antitumor': [183, 203], 'target.': [184], 'We': [185], 'investigated': [186], 'whether': [187], 'combinations': [188, 331], 'hTERT': [190, 228, 367, 382, 496, 532, 703], 'antisense': [191, 704, 775, 807], '(AS)-oligonucleotides': [192], '(ODNs)': [193], 'common': [195], '(CT)': [197], 'schedules': [198], 'may': [199], 'improve': [200], 'drug': [201, 358], 'mediated': [202], 'effects.': [204], 'Materials': [205], 'Methods:': [207], 'Initial': [208], 'screening': [209], 'for': [210, 619], 'enhancement': [211, 306], 'inhibitory': [214], 'effects': [215, 359], 'MMC,': [217], 'on': [221, 360, 757, 778], 'viability': [222, 290, 314], 'treatment': [224, 466], '2': [227, 413], 'AS-ODNs': [229, 368], 'ASt2206': [230], 'ASt2331': [232, 310, 328], 'was': [233, 244, 348], 'performed': [234], 'in': [235, 265, 284, 297, 317, 324, 375, 386, 464, 685, 711, 734, 784, 811, 815], '4': [236, 457], 'TCC': [237, 364], 'lines': [239, 271], 'prior': [240], 'CT.': [242, 345], 'Apoptosis': [243, 346, 415], 'assessed': [245], 'annexin': [247], 'V': [248], 'staining': [249], 'detection': [251], 'activated': [253], 'caspase-3': [254], 'using': [255], 'Western': [256], 'blot': [257], 'analysis.': [258], 'Nonsense': [259], '(NS)-ODN': [260], 'served': [261], 'control': [264, 296], 'all': [266], 'experiments.': [267], 'Results:': [268], 'responded': [272], 'anticancer': [275, 646], 'tested.': [277], 'Treatment': [278], 'AS': [280, 304], 'plus': [281, 294, 311, 321, 329, 344], 'CT': [282, 295, 330], 'resulted': [283], 'significantly': [286], 'stronger': [287], 'inhibition': [288, 497, 615], 'than': [291], 'NS': [293, 320, 343], 'combinations,': [301], 'indicating': [302], 'an': [303, 806], 'specific': [305, 388], 'effect.': [307], 'For': [308], 'example,': [309], 'MMC': [312, 322], 'decreased': [313], '17%': [316], 'contrast': [318], '(58%)': [323], 'EJ28': [325], 'cells.': [326, 506, 582, 624, 688], 'increased': [333], 'rate': [335], 'apoptosis': [337, 568, 710, 751, 783], '1.3': [338], '3.0-fold': [340], 'compared': [341], 'induction': [347], 'associated': [349], 'caspase': [351], '3': [352, 440], 'activation.': [353], 'Conclusions:': [354], 'Enhancement': [355], 'cytotoxic': [357, 445], 'growth': [362, 501], 'cells': [365, 419, 520, 601, 644], 'presented': [369], 'herein': [370], 'allows': [371], 'dose': [373], 'decrease': [374], 'confirms': [378], 'suitability': [380], 'target': [385], 'therapy': [389], 'approach.': [390], 'References': [391], '1': [392], ':': [393, 414, 441, 458, 479, 494, 515, 531, 550, 566, 590, 611, 632, 656, 674, 697, 721, 746, 771, 798], 'Management': [394], 'superficial': [396], 'bladder.': [402], 'Hosp': [403], 'Phys': [404], 'Urol': [405], 'Board': [406], 'Rev': [407], 'Man2002;': [408], '10:': [409], '2.': [410], 'Google': [411, 438, 455, 476, 491, 512, 528, 547, 563, 587, 608, 629, 653, 671, 694, 718, 743, 768, 795, 825], 'Scholar': [412, 439, 456, 477, 492, 513, 529, 548, 564, 588, 609, 630, 654, 672, 695, 719, 744, 769, 796, 826], 'cancer': [418, 505, 623, 664, 687, 760], 'induced': [420, 752], 'short-term': [422], 'low-dose': [424], 'Mitomycin-C:': [425], 'potential': [426], 'molecular': [427, 448, 727], 'mechanism': [428], 'clinical': [430], 'implication.': [431], 'Int': [432, 689], 'J': [433, 471, 649, 690, 738, 764, 790], 'Mol': [434], 'Med2003;': [435], '11:': [436], '389.': [437], 'Cisplatin:': [442], 'mode': [443], 'action': [446], 'basis': [449], 'resistance.': [451], 'Oncogene2003;': [452, 544], '22:': [453, 545], '7265.': [454], 'Gemcitabine:': [459], 'promising': [461], 'new': [462], 'agent': [463], 'advanced': [468, 818], 'urothelial': [469], 'cancer.': [470, 737, 819], 'Clin': [472, 507, 820], 'Oncol1997;': [473], '15:': [474], '3441.': [475], '5': [478], 'Determinants': [480], 'resistance': [482], '2′,2′-difluorodeoxycytidine': [484], '(gemcitabine).': [485], 'Drug': [486], 'Resist': [487], 'Updat2002;': [488], '5:': [489], '19.': [490], '6': [493], 'Antisense-mediated': [495], 'reduces': [499], 'Cancer': [508, 625, 821], 'Res2003;': [509, 626, 822], '9:': [510, 823], '3794.': [511], '7': [514], 'Creation': [516], 'tumour': [519], 'defined': [522], 'genetic': [523], 'elements.': [524], 'Nature1999;': [525], '400:': [526], '464.': [527], '8': [530], 'associates': [533], 'telomeres': [536], 'enhances': [538, 679], 'genomic': [539], 'stability': [540], 'DNA': [542], 'repair.': [543], '131.': [546], '9': [549], 'TERT': [551], 'regulates': [552], 'survival': [554], 'independent': [555], 'enzymatic': [558], 'activity.': [559], 'Oncogene2002;': [560], '21:': [561, 692], '3130.': [562], '10': [565], 'Non-caspase-mediated': [567], 'potent': [572], 'cytotoxicity': [573], 'enediyne': [576], 'antibiotic': [577], 'lidamycin': [578], 'toward': [579], 'Biochem': [583], 'Pharmacol2003;': [584], '65:': [585], '1767.': [586], '11': [589], 'Inhibition': [591, 675, 698], 'increases': [594, 705], 'susceptibility': [596, 733], 'malignant': [599], 'glioblastoma': [600], 'cisplatin-induced': [603], 'apoptosis.': [604], 'Oncogene1998;': [605], '16:': [606], '2243.': [607], '12': [610], 'Consequences': [612], 'combination': [617, 812], 'treatments': [618], 'proliferation': [621], '63:': [627], '5917.': [628], '13': [631], 'Attenuation': [633], 'activity': [636, 701], 'does': [637], 'not': [638], 'increase': [639], 'sensitivity': [640], 'melanoma': [643], 'agents.': [647], 'Eur': [648, 763], 'Cancer2000;': [650], '36:': [651], '2137.': [652], '14': [655], 'A': [657, 799, 913], 'highly': [658], 'selective': [659], 'inhibitor': [661, 808], 'limiting': [662], 'proliferation.': [666], 'EMBO': [667], 'J2001;': [668], '20:': [669], '6958.': [670], '15': [673], 'effect': [681, 707, 773], 'chemotherapeutic': [683], 'lung': [686, 759], 'Oncol2002;': [691], '1087.': [693], '16': [696], 'CDDP-induced': [709], 'myeloid': [712], 'leukemia.': [713], 'Hematol': [714], 'J2002;': [715], '3:': [716], '201.': [717], '17': [720], 'Functional': [722], 'p53': [723], 'mutation': [724], 'determinant': [728], 'paclitaxel': [730], 'Urol2001;': [739, 791], '166:': [740, 792], '482.': [741], 'Link,': [742, 794], '18': [745], 'Cell': [747, 885], 'cycle': [748], 'disturbances': [749], 'topotecan': [754], 'lines.': [762], 'Cancer1999;': [765], '35:': [766], '796.': [767], '19': [770], 'The': [772], 'Bcl-2': [776, 779], 'oligonucleotides': [777], 'protein': [780], 'expression': [781], 'carcinoma.': [789], '1098.': [793], '20': [797], 'phase': [800], 'I': [801], 'trial': [802], 'ISIS': [804], '2503,': [805], 'H-ras,': [810], 'patients': [816], '115.': [824], 'From': [827], 'Department': [829], 'Urology': [831], 'Institute': [833], 'Pathology': [835], '(MK),': [836], 'Technical': [837], 'University': [838], 'Dresden,': [839, 840], 'Germany©': [841], '2004': [842, 958], 'American': [844, 960], 'Urological': [845, 961], 'Association,': [846, 962], 'Inc.FiguresReferencesRelatedDetailsCited': [847], 'byXiao': [848], 'W,': [849, 855], 'Wang': [850], 'J,': [851, 867], 'Li': [852], 'H,': [853, 861], 'Guan': [854], 'Xia': [856], 'D,': [857], 'Yu': [858], 'G,': [859], 'Xiao': [860], 'Lang': [862], 'B,': [863], 'Ma': [864], 'X,': [865, 869], 'Liu': [866], 'Zhang': [868], 'Ye': [870], 'Z': [871], 'Xu': [873], 'H': [874], '(2018)': [875, 917], 'Fibulin-1': [876], 'Down-Regulated': [878], 'Through': [879], 'Promoter': [880], 'Hypermethylation': [881], 'Suppresses': [883], 'Renal': [884], 'Carcinoma': [886], 'ProgressionJournal': [887], 'Urology,': [889, 939], 'VOL.': [890, 940], '190,': [891], 'NO.': [892, 942], '1,': [893, 943], '(291-301),': [894], 'Online': [895, 945], 'publication': [896, 946], 'date:': [897, 947], '1-Jul-2013.KRAUSE': [898], 'S,': [899, 905], 'FÖRSTER': [900], 'Y,': [901], 'K,': [903], 'M,': [907, 911], 'U,': [909], 'SCHWENZER': [915], 'B': [916], 'VASCULAR': [918], 'ENDOTHELIAL': [919], 'GROWTH': [920], 'FACTOR': [921], 'PRETREATMENT': [923], 'CELLS': [927], 'SIGNIFICANTLY': [928], 'ENHANCES': [929], 'THE': [930], 'CYTOTOXICITY': [931], 'MITOMYCIN': [933], 'C,': [934], 'GEMCITABINE': [935], 'AND': [936], 'CISPLATINJournal': [937], '174,': [941], '(328-331),': [944], '1-Jul-2005.': [948], 'Volume': [949], '172Issue': [950], '5November': [951], '2004Page:': [952], '2023-2028': [953], 'Advertisement': [954, 1036], 'Copyright': [955], '&': [956], 'Permissions©': [957], 'Inc.Keywordsbladdertelomerasedrug': [963], 'therapybladder': [964], 'neoplasmsoligonucleotides,': [965], 'antisenseMetricsAuthor': [966], 'Information': [967], 'Expand': [1034], 'PDF': [1037], 'downloadLoading': [1038], '...': [1039]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2036588461', 'counts_by_year': [{'year': 2018, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 2}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-09-24T01:32:18.107938', 'created_date': '2016-06-24'}